There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Zomedica Corp. (ZOM) shows that investor sentiment remained same, with the stock’s consolidated last price remained same by $0.00, or 2.31%, to $0.17. The Zomedica Corp. has recorded 700,238 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans.
As a AMEX listed company, ZOM falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. At the end of the last regular session, the stock closed at $0.17 and fluctuated between $0.1690 as its day high and $0.1601 as its day low. The current market capitalization of Zomedica Corp. is $166.10M. A total of 4.04 million shares were traded on the day, compared to an average of 6.10M shares.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for ZOM in the last 3 months, the mean price target is $1.20 with high estimates of $1.20 and low estimates of $1.20. In terms of 52-week highs and lows, ZOM has a high of $0.50 and a low of $0.15.
As of this writing, ZOM has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 0 estimates, with a high estimate of $0 per share and a lower estimate of $0.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 1 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZOM is Buy with a score of 0.00. A total of 1 analysts rated the stock as Buy while 0 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.